Intravenous Immunoglobulin Market by Component (IgG, IgA, IgM, IgE, and IgD), by Application (Immunodeficiency Diseases, Chronic Inflammatory Demyelinating Polyneuropathy, Myasthenia Gravis, Idiopathic Thrombocytopenic Purpura, Hypogammaglobulinemia, Multifocal Motor Neuropathy, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre Syndrome, and Others), by End-User (Hospitals, Clinics, and Homecare Settings), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024–2032

The global Intravenous Immunoglobulin Market size was valued USD 11.69 bn in 2023 and is expected to rise to USD 22.01 bn by 2032 at a CAGR of 7.28%.

全球静脉注射免疫球蛋白市场规模在2023年达到了116.9亿美元，预计到2032年将增长至220.1亿美元，年复合增长率达到7.28%。